Kenox Pharmaceuticals (Princeton, NJ) is a specialty contract development, manufacturing, and testing organization focused on nasal, inhalation, and ophthalmic drug products. Kenox provides end-to-end support spanning early-stage research, formulation and analytical development, IVBE testing, compounding, fill-finish, and GMP clinical manufacturing, enabling seamless progression from concept through Phase I and II clinical supply.

Kenox’s expertise spans both non-sterile and sterile drug-device combination products, supporting quality, reliability, and regulatory alignment across a wide range of development programs. Our teams bring deep technical knowledge and broad industry experience in complex delivery platforms, including soft mist inhalers (SMIs), dry powder inhalers (DPIs), nebulizers, nasal sprays, and other advanced aerosol technologies. We support development programs involving small molecules, peptides, and biologics.